Market Overview The molecular diagnostics in infectious disease testing market is expanding rapidly as laboratories move away from slower culture-based methods toward nucleic acid amplification and sequencing technologies. Hospitals, reference labs, and point-of-care settings are investing in PCR, isothermal amplification, and next-generation sequencing platforms to identify bacterial, viral,...